Menu

Suspected Yellow Fever Outbreak in Brazil

According to the World Health Organization, relatively low vaccination coverage in the state of Minas Gerais “could favor the rapid spread of the disease.”

Jan 19, 2017
Tracy Vence

WIKIMEDIA, CDCMore than 120 people may have been infected with the Yellow Fever virus in Brazil since December, according to the World Health Organization (WHO). Thirty of them have died. In a January 13 report, the WHO noted that relatively low vaccination coverage in one region where the virus is suspected to be spreading, in the state of Minas Gerais, “could favor the rapid spread of the disease.”

Last week, the governor of Minas Gerais declared a state of emergency. “A spokeswoman for the Minas Gerais State Health Secretariat said all the cases reported so far were sylvatic, meaning that the infection has been passed by mosquitoes in the wild, in rural areas where monkeys are known to carry the disease,” The New York Times reported.

If confirmed, this would not be the first Yellow Fever outbreak in the region. An outbreak in 2002 and 2003 tallied 63 confirmed cases, including 23 deaths, the WHO noted.

“We know the virus has a cyclical behavior, and from time to time we see activity in areas of transmission. But each time this happens it is of concern because we could see the return of yellow fever to Aedes aegypti mosquitoes in urban areas,” Jesse Alves of the Emilio Ribas Hospital in São Paulo told The New York Times.

The response to this suspected outbreak is “further complicated by the fact that it is occurring in the context of concomitant outbreaks of Zika virus, chikungunya and dengue,” according to the WHO.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.